Received: 16 August 2019
Accepted: 21 September 2019
First Online: 10 December 2019
Ethics approval and consent to participate
: Cleveland Clinic Investigational Review Board (IRB Study # 15-080); Because this study is a retrospective chart review, informed consent was neither required or collected.
: Not applicable.
: RPS: Regeneron (grants and personal fees), Genentech/Roche (grants and personal fees), Alcon/Novartis (grants and personal fees), Apellis (grants), Optos (personal fees), Zeiss (personal fees), Bausch & Lomb (personal fees), during the conduct of the study; FFC, WS, and EBR: None. None of the authors have a proprietary interest in this study.This study was fully performed at Cole Eye Institute, Cleveland Clinic Foundation, Ohio, USA.